| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/06/2013 | CN102362924B Medicinal composition for treating ophthalmic diseases and preparation method thereof |
| 03/06/2013 | CN101919810B Dexpanthenol infusion preparation and preparation method thereof |
| 03/06/2013 | CN101443004B Formulations and methods for vascular permeability-related diseases or conditions |
| 03/05/2013 | US8389496 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/28/2013 | WO2013028880A1 Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| 02/28/2013 | WO2013027895A1 Composition for inhibiting angiogenesis containing a peroxidasin inhibitor as an active ingredient |
| 02/28/2013 | WO2013027222A1 (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders |
| 02/28/2013 | WO2013026557A1 Vasoconstrictor-containing agent for combination therapy |
| 02/28/2013 | WO2013003467A3 Methods for treating ocular inflammatory disorders |
| 02/28/2013 | WO2012158910A3 Compositions and methods for treating retinal diseases |
| 02/28/2013 | US20130053444 Dp2 antagonist and uses thereof |
| 02/28/2013 | US20130053440 Self-Preserved Aqueous Pharmaceutical Compositions |
| 02/28/2013 | US20130053438 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 02/28/2013 | US20130053431 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 02/28/2013 | US20130053425 Method for Lowering Intraocular Pressure Using Gap Junction Blockers |
| 02/28/2013 | US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053374 Ophthalmic composition |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130053353 Compositions, gels and foams with rheology modulators and uses |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053336 Treatment of chlamydiaceae infections by means of beta-lactams |
| 02/28/2013 | US20130053328 Compositions and methods of inhibiting photoreceptor apoptosis |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130052286 Composition for treatment of aesthenopia |
| 02/28/2013 | US20130052284 Palm kernel oil-based intranasal composition and use |
| 02/28/2013 | US20130052266 TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND |
| 02/28/2013 | US20130052214 Identification of a peptide(s) that induces autoimmune anterior uveitis |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052190 CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/28/2013 | CA2846011A1 (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders |
| 02/28/2013 | CA2844775A1 Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| 02/27/2013 | EP2561883A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561882A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561881A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2560629A2 Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells |
| 02/27/2013 | EP2560616A2 Artificial tear emulsion |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947315A Inhibitors of protein tyrosine kinase activity |
| 02/27/2013 | CN102947281A Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 02/27/2013 | CN102946883A Method and ophthalmic composition for treating retinal disease |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102943018A Kidney-tonifying and eyesight-improvement papermulberry fruit health-care wine |
| 02/27/2013 | CN102942567A Disodium salt crystal of pyrroloquinoline quinone |
| 02/27/2013 | CN102942546A New compound used for preparing eye drops |
| 02/27/2013 | CN102940867A Chinese medicinal composition for treating xerophthalmia |
| 02/27/2013 | CN102940826A Traditional Chinese medicinal liquor for treatment of diabetic retinopathy |
| 02/27/2013 | CN102940753A Pills for treating glaucoma and preparation method |
| 02/27/2013 | CN102940745A Pill for treating blepharospasm |
| 02/27/2013 | CN102940739A Chinese medicinal composition for treating vernal keratoconjunctivitis |
| 02/27/2013 | CN102940706A Traditional Chinese medicine composition for treating fundus hemorrhage |
| 02/27/2013 | CN102940633A Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus |
| 02/27/2013 | CN102379867B Use of chicoric acid in treatment of fundus lesion |
| 02/27/2013 | CN102370906B Traditional Chinese medicinal combination with function of relieving asthenopia and preparation method thereof |
| 02/27/2013 | CN102327333B Chinese medicine for treating eye diseases caused by exogenous wind pathogen and preparation method thereof |
| 02/27/2013 | CN102319323B Eyedrop for reducing intraocular pressure and treating glaucoma and preparation method thereof |
| 02/27/2013 | CN102302686B Medicament for treating xerophthalmia |
| 02/27/2013 | CN102178796B Application of active ingredients of juncus effuses in preparation of medicaments for resisting tumors or inhibiting angiogenesis, health-care food or cosmetics |
| 02/27/2013 | CN101626762B Solvating system and sealant for medical use |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/26/2013 | US8383650 Organic compounds |
| 02/26/2013 | US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/21/2013 | WO2013025840A1 Methods for preserving photoreceptor cell viability following retinal detachment |
| 02/21/2013 | WO2013025696A1 Ophthalmic formulations and processes for their preparation |
| 02/21/2013 | WO2013025628A1 Janus kinase inhibitor compounds and methods |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2013000895A9 Dha and epa in the reduction of oxidative stress |
| 02/21/2013 | US20130046014 Pharmaceutical composition for treatment of increased intraocular pressure |
| 02/21/2013 | US20130046007 Selective reduction of allelic variants |
| 02/21/2013 | US20130046003 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
| 02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
| 02/21/2013 | US20130045957 Prevention of and Recovery from Drug-Induced Ototoxicity |
| 02/21/2013 | US20130045943 A3ar agonists for the treatment of uveitis |
| 02/21/2013 | US20130045940 Composition comprising as active ingredient l-carnitine in combination with a solar filter, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| 02/21/2013 | US20130045927 Therapeutic compositions for the treatment of dry eye disease |
| 02/21/2013 | US20130045926 Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045204 Fluorinated bisphenol ether compounds and methods for their use |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/20/2013 | EP2558104A1 Method and ophthalmic composition for treating retinal disease |
| 02/20/2013 | EP2558100A1 Compositions and methods for treating visual disorders |
| 02/20/2013 | EP2558081A2 Intraocular pressure reduction with intracameral bimatoprost implants |
| 02/20/2013 | CN102939099A Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 02/20/2013 | CN102939092A Gamma-polyglutamic acid-based ocular irrigating solutions |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |